Acute Porphyria Drug Database

Monograph

A07AA09 - Vancomycin
Propably not porphyrinogenic
PNP

Rationale
Glycopeptide. Probably insignificant systemic exposure. Three references consider it safe.
Chemical description
Tricyclic glycopeptide antibioticum used in enterocolitis caused by Clostridium difficile. Given perorally in a dose of 500 mg (2 g) /d for 10-14 days.Only minute amounts are absorbed South African list: use. French list: authorized. Michael Moore's list: safe
Similar drugs
Explore alternative drugs in similar therapeutic classes A07A / A07AA or go back.
Tradenames
This list comprises raw data collected from different countries. In some cases, a more comprehensive list of available drug packages is included. Consequently, very similar terms may therefore appear multiple times. Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.


Vancocin CP 250 mg, capsules · Vancomycine ERC 250 mg, harde capsules · Vancomycine Eureco-Pharma 250 mg harde capsules · Vancomycine Medcor 250 mg, harde capsules · Vancomycine Strides 125 mg harde capsules · Vancomycine Strides 250 mg harde capsules Levovanox · Maxivanil LEVOVANOX 250 mg · VANCOCIN MATRIGEL 125 mg Vancocin Matrigel · Vancomycin Vancocin · Vancomycin Strides Vancomycin Strides Vancomycin ENTEROCAPS Vancomycin Xellia Vancomycin Strides · Vancomycin Xellia Vanocin
 
© NAPOS 2025
An unhandled error has occurred. Reload 🗙